Online citations, reference lists, and bibliographies.
← Back to Search

Drug Delivery Nanoparticles Formulation And Characterization

Y. Pathak, Deepak Thassu
Published 2009 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1042/BST0350041
Challenges to macromolecular drug delivery.
R. Juliano (2007)
10.1016/S0378-5173(02)00701-9
Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs.
C. Duclairoir (2003)
10.1111/1523-1747.EP12478060
Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode.
C. Cullander (1991)
10.1002/047147875x
Principles of polymerization
G. Odian (1981)
10.1002/JPS.20902
Importance of divalent cations in nanolipoplex gene delivery.
M. Mozafari (2007)
10.1023/A:1016064930502
Albumin Nanospheres as Carriers for Passive Drug Targeting: An Optimized Manufacturing Technique
B. Müller (2004)
10.1021/BK-1976-0033
Controlled Release Polymeric Formulations
D. Paul (1976)
10.1002/JPS.20853
Enzybiotics: a look to the future, recalling the past.
P. Veiga-Crespo (2007)
10.1021/BM0501961
Phospholipid-stabilized Au-nanoparticles.
Peng He (2005)
10.1016/J.JCONREL.2007.04.009
Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Kyeongsoon Park (2007)
10.1016/J.AB.2004.07.038
A comparison of different strategies for the construction of amperometric enzyme biosensors using gold nanoparticle-modified electrodes.
M. L. Mena (2005)
10.1021/BC049905I
Magneto/optical annexin V, a multimodal protein.
Eyk A Schellenberger (2004)
10.1186/1743-8977-2-8
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy
G. Oberdörster (2005)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1016/0142-9612(95)93260-K
In vivo and in vitro elimination of aliphatic polyanhydrides.
A. Domb (1995)
10.1016/j.jsbmb.2008.05.004
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice
Manuela Banciu (2008)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1021/BC9600269
Biochemical Characterization of an L-Asparaginase Bioconjugate
Martins Mb (1996)
10.1016/S0142-9612(99)00229-X
Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo.
A. Bielinska (2000)
10.1016/S0168-3659(02)00406-6
Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin-incompatibility of the lipid and the pyrethroid and biological properties of the formulations.
H. Frederiksen (2003)
10.1111/j.1600-0625.2007.00584.x
Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA–cationic deformable liposome complex
J. Wang (2007)
10.1007/S00216-003-2199-0
Protease sensors for bioimaging
M. Funovics (2003)
10.1016/j.nano.2007.11.004
Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
S. Jain (2008)
10.1073/PNAS.0601755103
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
10.1016/S1359-6446(01)01757-3
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications.
R. Esfand (2001)
10.1016/J.IJPHARM.2006.08.007
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
J. Liu (2007)
10.1246/CL.2006.1046
Smart PEGylated Gold Nanoparticles for the Cytoplasmic Delivery of siRNA to Induce Enhanced Gene Silencing
Motoi Oishi (2006)
Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
D. O'hagan (1990)
10.1073/PNAS.0401137101
Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate.
V. Ntziachristos (2004)
10.1016/S0956-5663(03)00172-6
Reagentless glucose biosensor based on direct electron transfer of glucose oxidase immobilized on colloidal gold modified carbon paste electrode.
S. Liu (2003)
10.1016/J.JCONREL.2005.09.023
Gelatin as a delivery vehicle for the controlled release of bioactive molecules.
S. Young (2005)
The separation and characterization of the alpha- and beta-components of calf skin collagen.
K. Piez (1960)
10.1016/S0009-2614(98)00277-2
Nanoengineering of optical resonances
S. Oldenburg (1998)
10.1016/J.BIOS.2004.09.023
Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantilevers.
Kyung Wook Wee (2005)
10.1182/BLOOD-2003-02-0378
Generation and role of angiostatin in human platelets.
P. Jurasz (2003)
10.1016/J.EURURO.2005.04.011
Liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease: a randomized placebo-controlled double-blind prospective clinical study.
C. Riedl (2005)
10.1016/0300-9084(90)90050-Q
Acylation of L-asparaginase with total retention of enzymatic activity.
M. B. Martins (1990)
10.1002/ELPS.1150170332
Plasma protein adsorption patterns on liposomes: Establishment of analytical procedure
J. Diederichs (1996)
10.1038/sj.bjp.0704559
Mechanisms of action of proteinase‐activated receptor agonists on human platelets
A. Chung (2002)
10.1016/S0168-3659(97)00246-0
Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.
E. Fattal (1998)
10.1016/S0378-5173(01)00759-1
Transdermal permeation of apomorphine through hairless mouse skin from microemulsions.
E. Peira (2001)
10.1124/MOL.105.017400
Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation
S. Aggarwal (2006)
10.1080/10611860290031868
Intravenous Administration to Rabbits of Non-stealth and Stealth Doxorubicin-loaded Solid Lipid Nanoparticles at Increasing Concentrations of Stealth Agent: Pharmacokinetics and Distribution of Doxorubicin in Brain and Other Tissues
G. Zara (2002)
10.1038/sj.bjp.0706761
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells
C. Dianzani (2006)
Drug-loaded nanoparticles – preparation methods and drug targeting issues
E. Alleman (1993)
10.1007/s10439-007-9423-6
The Transport of Nanoparticles in Blood Vessels: The Effect of Vessel Permeability and Blood Rheology
F. Gentile (2007)
10.1021/JA055321V
Size-controlled synthesis of near-monodisperse gold nanoparticles in the 1-4 nm range using polymeric stabilizers.
I. Hussain (2005)
10.1021/JA001652Q
Surface-initiated atom transfer radical polymerization on gold at ambient temperature
J. B. Kim (2000)
10.1016/J.EJPS.2005.04.009
Microencapsulated chitosan nanoparticles for lung protein delivery.
A. Grenha (2005)
Gelatin nanoparticles as a new and simple gene delivery system.
Klaus Zwiorek (2005)
10.1039/B100575H
Novel dendron-stabilized gold nanoparticles with high stability and narrow size distribution
Minkyu Kim (2001)
10.1016/j.addr.2008.03.018
Magnetic nanoparticles in MR imaging and drug delivery.
C. Sun (2008)
10.1002/jps.21340
Recent pharmaceutical applications of Raman and terahertz spectroscopies.
C. McGoverin (2008)
10.1007/PL00000774
Sialyl Lewisx-liposomes as vehicles for site-directed, E-selectin-mediated drug transfer into activated endothelial cells
R. Stahn (2001)
10.1016/0168-3659(94)90039-6
Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery
H. Schreier (1994)
10.1016/j.addr.2008.08.002
Hydrogel nanoparticles in drug delivery.
M. Hamidi (2008)
10.1080/02652040110055207
α-Tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles
C. Duclairoir (2002)
10.1002/JPS.20718
Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?
L. Illum (2007)
10.1016/J.MATERRESBULL.2006.10.014
Phospholipid-assisted synthesis of size-controlled gold nanoparticles
P. He (2007)
10.1016/0142-9612(95)93259-G
Development of a drug delivery system for the treatment of periodontal disease based on bioerodible poly(ortho esters).
K. Roskos (1995)
10.1002/JPS.20745
Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.
Cheng Yiyun (2007)
10.1111/j.1747-0285.2005.00324.x
Stability of Gold Nanoparticle‐Bound DNA toward Biological, Physical, and Chemical Agents
G. Han (2006)
10.1016/J.BIOMATERIALS.2004.02.013
Microspheres of corn protein, zein, for an ivermectin drug delivery system.
X. Liu (2005)
10.1016/J.EJPB.2007.04.006
Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream.
A. Teichmann (2007)
10.1016/S0169-409X(01)00158-2
Veterinary drug delivery: potential for skin penetration enhancement.
B. Magnusson (2001)
10.1002/SMLL.200500172
Synthesis of gold nanoparticles using multifunctional peptides.
J. Slocik (2005)
10.1007/s00109-005-0669-x
Topical application of plasmid DNA to mouse and human skin
N. Meykadeh (2005)
10.1002/JPS.20750
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
F. Cui (2007)
10.1002/anie.200705240
A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination.
S. Lee (2008)
10.1177/153303460500400408
Nanotechnology-based Drug Delivery for Cancer
K. Jain (2005)
10.1002/cncr.20605
Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis
L. Li (2004)
10.1016/S0378-5173(99)00439-1
Study on glycolic acid delivery by liposomes and microspheres.
P. Perugini (2000)
10.1016/S0091-6749(97)70204-5
Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines.
T. Kumagai (1997)
10.1006/TAAP.1995.1032
Evaluation of liver toxicological effects induced by polyalkylcyanoacrylate nanoparticles.
R. Fernández-Urrusuno (1995)
10.1201/9781420008449
Nanoparticulate Drug Delivery Systems
Deepak Thassu (2007)
10.1016/J.SURNEU.2006.08.033
Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
G. Silva (2007)
10.1016/J.BIOMATERIALS.2007.01.003
Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
Sie Huey Lee (2007)
10.1093/TOXSCI/KFJ127
Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
A. Isakovic (2006)
10.2147/IJN.S596
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
10.1016/S0928-0987(00)00169-X
Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.
M. Merodio (2001)
10.1016/j.ejpb.2008.09.003
Lipid nanoparticles for parenteral delivery of actives.
Medha D. Joshi (2009)
10.1562/0031-8655(2003)078<0587:TEOMIS>2.0.CO;2
The Embedding of Meta-tetra(Hydroxyphenyl)-Chlorin into Silica Nanoparticle Platforms for Photodynamic Therapy and Their Singlet Oxygen Production and pH-dependent Optical Properties¶
F. Yan (2003)
10.1016/S0169-409X(02)00227-2
Microfabricated drug delivery systems: from particles to pores.
S. Tao (2003)
10.1016/0142-9612(93)90121-H
Poly(L-lactide): a long-term degradation study in vivo. Part III. Analytical characterization.
H. Pistner (1993)
10.1002/JPS.2600830702
Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
G. Digenis (1994)
10.1088/0957-4484/19/46/465101
Nanotube-antibody biosensor arrays for the detection of circulating breast cancer cells.
N. Shao (2008)
10.1016/j.colsurfb.2008.07.004
Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
Ganeshchandra Sonavane (2008)
10.4103/0250-474X.27822
Clarithromycin based oral sustained release nanoparticulate drug delivery system
S. Ramteke (2006)
10.1038/7933
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
R. Weissleder (1999)
10.1021/bk-1976-0033.ch003
Controlled Release from Erodible Slabs, Cylinders, and Spheres
H. Hopfenberg (1976)
10.1016/S0378-5173(99)00361-0
Lecithin vesicular carriers for transdermal delivery of cyclosporin A.
J. Guo (2000)
10.1038/nmeth875
Metabolic biotinylation of cell surface receptors for in vivo imaging
B. Tannous (2006)
10.1016/J.TIV.2004.02.001
Experimental survey of non-clonogenic viability assays for adherent cells in vitro.
Ingrida Mickuviene (2004)
10.1016/S1367-5931(02)00356-3
Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents.
E. Sevick-Muraca (2002)
[Erythrocyte native immune adhering function (ENIAF) in patients with hematopoietic and lymphoid neoplasms and its effect on NK Cell killing activity].
Nai-Hong Zhang (2007)
10.1038/nm1096
Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy
E. B. Voura (2004)
10.1016/S0169-409X(96)00401-2
Polymeric micelles as new drug carriers
G. Kwon (1996)
10.1016/0168-3659(95)00047-C
Novel developments in liposomal delivery of peptides and proteins
G. Storm (1995)
10.1016/J.IJPHARM.2003.10.038
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
A. Kohli (2004)
10.1038/nnano.2007.223
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)
10.1016/J.EJPB.2006.09.004
Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
K. Derakhshandeh (2007)
Submicron encapsulation of organic sunscreens
D. Fairhurst (1995)
10.1016/J.JCONREL.2005.06.006
Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
K. Manjunath (2005)
10.1093/JAC/DKG477
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
R. Pandey (2003)
10.1023/A:1016290704772
Acute Renal Toxicity of Doxorubicin (Adriamycin)-Loaded Cyanoacrylate Nanoparticles
L. Manil (2004)
10.1080/10837450500299727
Solid Lipid Microparticles (SLM) Containing Juniper Oil as Anti-Acne Topical Carriers: Preliminary Studies
E. Gavini (2005)
10.1016/J.TIBTECH.2005.02.007
Nanobiotechnology: the promise and reality of new approaches to molecular recognition.
P. Fortina (2005)
10.1016/S0733-8635(05)70412-5
Cutaneous gene therapy.
P. Khavari (1997)
10.1021/AR9602664
Monolayer-protected cluster molecules.
A. C. Templeton (2000)
10.1042/BJ20031253
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
10.1038/nnano.2008.114
Seven challenges for nanomedicine.
W. Sanhai (2008)
10.1201/9781498710565
Colloidal Drug Delivery Systems
J. Kreuter (1994)
10.1016/J.FOODHYD.2007.02.005
Characterization of the morphology and thermal properties of Zein Prolamine nanostructures obtained by electrospinning
S. Torres-Giner (2008)
10.1016/S0169-409X(99)00068-X
Gene-transfer systems for human endothelial cells
S. Martin (2000)
10.1074/jbc.M511562200
Real Time Single Cell Analysis of Bid Cleavage and Bid Translocation during Caspase-dependent and Neuronal Caspase-independent Apoptosis*
M. W. Ward (2006)
10.1006/ABIO.1997.2220
Fluorometric and colorimetric detection of caspase activity associated with apoptosis.
V. Gurtu (1997)
10.1002/LSM.20577
The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy
Xiaohua Huang (2007)
10.1016/J.ADDR.2003.09.001
Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery.
B. Ziaie (2004)
10.1080/10611860400011935
Polymeric micelles for delivery of poorly soluble drugs: Preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids
Junping Wang (2005)
10.1002/ANIE.200504599
Laser-induced release of encapsulated materials inside living cells.
A. Skirtach (2006)
10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W
Ricinoleic acid-based biopolymers.
D. Teomim (1999)
10.1023/A:1018979126326
Albumin Microspheres as a Drug Delivery System: Relation Among Turbidity Ratio, Degree of Cross-linking, and Drug Release
Orapin P. Rubino (2004)
10.1016/S0168-3659(99)00055-3
Transdermal iontophoretic delivery of enoxacin from various liposome-encapsulated formulations.
J. Fang (1999)
10.1088/0957-4484/19/48/485103
Core/shell nanoparticles for multiple biological detection with enhanced sensitivity and kinetics.
A. Fauré (2008)
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
M. Alley (1988)
10.1016/J.IJPHARM.2007.03.006
Cationic transfersomes based topical genetic vaccine against hepatitis B.
S. Mahor (2007)
10.1002/JBM.820200510
Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules.
G. Visscher (1986)
10.1016/J.BIOS.2003.10.015
RCA combined nanoparticle-based optical detection technique for protein microarray: a novel approach.
H. Hsu (2004)
10.1016/J.CHEMBIOL.2003.12.017
Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter.
Benedict Law (2004)
10.1021/MA034265K
Preparation of poly(N-isopropylacrylamide)-monolayer protected gold clusters: synthesis methods, core size and thickness of monolayer
J. Shan (2003)
10.1021/LA040002N
Aggregation of photolytic gold nanoparticles at the surface of chitosan films.
T. Miyama (2004)
Liposomes as drug carriers : recent trends and progress
G. Gregoriadis (1988)
10.1080/02652040701288519
Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne
G. A. Castro (2007)
10.1201/9781420027990.pt2
Drug release from microparticulate systems
C. Washington (1996)
10.1002/JPS.2600710708
Square root of time dependence of matrix formulations with low drug content.
H. Fessi (1982)
10.1021/ac980588g
Preparation and characterization of dendrimer-gold colloid nanocomposites.
M. E. García (1999)
10.1016/J.IJPHARM.2006.07.046
Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
M. Nikanjam (2007)
10.1016/J.IJPHARM.2004.12.010
Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer
D. Shenoy (2005)
10.1016/J.IJPHARM.2006.06.019
Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
S. Sajeesh (2006)
10.1023/A:1016419303727
The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation Method
R. Bodmeier (2004)
10.1016/S0958-1669(00)00082-3
Applications of nanotechnology to biotechnology commentary.
J. West (2000)
10.1002/JPS.10368
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.
R. Cavalli (2003)
10.1038/SJ.JID.5700248
Low-frequency sonophoresis: ultrastructural basis for stratum corneum permeability assessed using quantum dots.
S. Paliwal (2006)
10.1038/sj.bjc.6604483
Tumour-targeted nanomedicines: principles and practice
T. Lammers (2008)
10.1021/MP060045S
Synthesis of oligo(ethylenediamino)-beta-cyclodextrin modified gold nanoparticle as a DNA concentrator.
H. Wang (2007)
10.1007/BFB0027551
Poly(Ortho Esters)
J. Heller (1993)
10.1038/386616A0
Release of gelatinase A during platelet activation mediates aggregation
G. Sawicki (1997)
10.1021/JP021710P
Self-Assembled One-Dimensional Arrays of Gold−Dendron Nanocomposites
Shigehiro Nakao (2002)
10.1016/S0168-3659(97)00196-X
Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release.
M. M. Gasper (1998)
10.1016/0022-1759(88)90310-9
A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.
T. Decker (1988)
10.1016/S0005-2736(99)00176-5
Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy.
B. Van den Bergh (1999)
10.1016/J.JCONREL.2004.10.015
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology.
S. Freitas (2005)
10.1186/1743-8977-2-11
Carbon black nanoparticles induce type II epithelial cells to release chemotaxins for alveolar macrophages
P. G. Barlow (2005)
10.1021/JM050008P
Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis.
K. Bullok (2005)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
10.1016/S0378-5173(97)00311-6
Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique
R. Mueller (1998)
10.1166/JNN.2004.146
Biodistribution of carbon single-wall carbon nanotubes in mice.
H. Wang (2004)
10.1002/1521-3773(20010202)40:3<549::AID-ANIE549>3.0.CO;2-P
Dendron-Controlled Nucleation and Growth of Gold Nanoparticles.
Ruiyao Wang (2001)
10.1021/LA034818K
Synthesis and self-assembly of cetyltrimethylammonium bromide-capped gold nanoparticles
W. Cheng (2003)
10.1093/TOXSCI/KFG243
Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation.
C. Lam (2004)
10.1517/14712598.7.5.587
Programmed drug delivery: nanosystems for tumor targeting
E. Wagner (2007)
10.1088/0957-4484/19/49/495101
Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin.
S. A. Kumar (2008)
10.1096/fasebj.11.8.9240963
Advances in adenoviral vectors: from genetic engineering to their biology
P. Yeh (1997)
10.1021/BM0497116
Synthesis of chitosan-stabilized gold nanoparticles in the absence/presence of tripolyphosphate.
Haizhen Huang (2004)
10.1002/JPS.21103
Cisplatin-incorporated hyaluronic acid nanoparticles based on ion-complex formation.
Y. Jeong (2008)
10.1007/BF00315035
Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection
C. Mallo (2004)
10.1016/S0378-5173(01)00627-5
Effect of liposomes and niosomes on skin permeation of enoxacin.
J. Fang (2001)
10.1023/A:1018888927852
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Shicheng Yang (2004)
10.1248/YAKUSHI.128.269
Lipid carriers: a versatile delivery vehicle for proteins and peptides.
M. Rawat (2008)
10.1152/PHYSREV.1971.51.4.702
Permeability of the Skin
R. Scheuplein (1971)
10.1016/J.ADDR.2005.12.003
Needle-free vaccine delivery.
E. Giudice (2006)
10.1111/J.2042-7158.1982.TB04767.X
Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form
M. Mezei (1982)
10.1016/J.LFS.2006.09.040
Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Fang Zheng (2007)
10.1177/00912700022009422
The Absolute Bioavailability of Oral Melatonin
R. L. DeMuro (2000)
10.1002/0471140856
Current protocols in toxicology
M. Maines (1999)
10.1016/J.EJPB.2004.05.010
The effect of cholate on solubilisation and permeability of simple and protein-loaded phosphatidylcholine/sodium cholate mixed aggregates designed to mediate transdermal delivery of macromolecules.
S. Simões (2004)
10.1016/0031-6865(95)00010-7
Preparation and characterization of liposomes as therapeutic delivery systems: a review.
S. Vemuri (1995)
10.1073/PNAS.88.18.8101
Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B.
S. Yao (1991)
10.1016/0378-5173(92)90249-2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size
E. Allémann (1992)
10.1385/1-59259-869-2:039
Sulforhodamine B assay and chemosensitivity.
W. Voigt (2005)
10.1073/PNAS.82.7.2158
Alkylating agent resistance: in vitro studies with human cell lines.
E. Frei (1985)
10.1038/420116a
Gene therapy: A tragic setback
E. Check (2002)
10.1080/10611860701794353
Polymeric nanoparticles for cancer therapy
S. Parveen (2008)
10.1021/J100204A077
LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS
I. Uchegbu (1992)
10.1016/S0024-3205(99)00068-5
In vitro evaluation of nanoparticles spleen capture.
M. Demoy (1999)
10.1016/S0168-3659(03)00302-X
Human serum albumin-polyethylenimine nanoparticles for gene delivery.
Stephanie Rhaese (2003)
10.1006/EXCR.1998.4110
Size of IgG-opsonized particles determines macrophage response during internalization.
Michael Koval (1998)
10.1021/JA025814P
Self-assembled nanoparticle probes for recognition and detection of biomolecules.
Dustin J. Maxwell (2002)
10.1007/978-3-662-22115-0
Long Circulating Liposomes: Old Drugs, New Therapeutics
M. Woodle (1998)
10.1016/J.CIS.2006.05.014
Microemulsions as transdermal drug delivery vehicles.
A. Kogan (2006)
10.1016/S1040-8428(01)00179-2
The cellular and molecular basis of hyperthermia.
B. Hildebrandt (2002)
10.1021/JM070657W
Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
H. Xu (2007)
10.1002/MDS.870060304
Absorption of apomorphine by various routes in parkinsonism
S. Gancher (1991)
10.1016/J.EJPB.2007.01.015
Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Veerawat Teeranachaideekul (2007)
10.1080/10611860600612953
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
V. Mishra (2006)
10.1196/annals.1329.054
Suppression of the Nuclear Factor‐κB Activation Pathway by Spice‐Derived Phytochemicals: Reasoning for Seasoning
B. Aggarwal (2004)
10.1016/J.TIV.2005.06.034
In vitro toxicity of nanoparticles in BRL 3A rat liver cells.
S. Hussain (2005)
10.1021/LA0700826
Preparation of poly(ethylene glycol)-modified poly(amido amine) dendrimers encapsulating gold nanoparticles and their heat-generating ability.
Y. Haba (2007)
10.1016/J.EJPS.2005.07.002
Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80.
S. Simões (2005)
10.1039/B413074J
Viral templates for gold nanoparticle synthesis
J. Slocik (2005)
10.1111/j.2040-1124.2010.00074.x
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
Y. Seino (2010)
10.1111/j.1442-9071.2007.01423.x
Contemporary in vivo confocal microscopy of the living human cornea using white light and laser scanning techniques: a major review
D. Patel (2007)
10.1289/ehp.8903
Effects of Airway Exposure to Nanoparticles on Lung Inflammation Induced by Bacterial Endotoxin in Mice
K. Inoue (2006)
10.1021/BC049899Q
Detection of apoptosis using the C2A domain of synaptotagmin I.
H. Jung (2004)
10.1021/bc800057g
Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.
P. McCarron (2008)
10.1073/pnas.0805135105
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
M. Lundqvist (2008)
10.1007/s00280-006-0256-z
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting
H. Lu (2006)
10.1021/MA00195A018
Solid-state and solution stability of poly(anhydrides) and poly(esters)
A. Domb (1989)
10.1002/JPS.10061
Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles.
Nalini Raghavachari (2002)
10.1016/S0378-5173(00)00562-7
Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel.
A. Miglietta (2000)
10.1208/pt050467
Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods
S. Dhawan (2008)
10.1016/J.TOXLET.2005.08.007
Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice.
Bing Wang (2006)
10.2174/156802608783955629
Developments on drug delivery systems for the treatment of mycobacterial infections.
M. M. Gaspar (2008)
10.1002/9780470152928.CH5
Dendrimers and Hyperbranched Polymers for Drug Delivery
R. M. Kannan (2007)
10.1016/0378-5173(96)04652-2
Enzyme-loaded PIBCA nanoparticles (SOD and l-ASNase): Optimization and characterization
M. Martins (1996)
10.1021/LA011445J
Photoinitiated polymerization of styrene from self-assembled monolayers on gold
Rolf K. Schmidt (2002)
10.1016/0032-3861(91)90143-7
Conformation of gelatin chains in aqueous solutions: 1. A light and small-angle neutron scattering study
I. Pezron (1991)
10.1042/BJ0580074
The N-terminal amino acid residues of gelatin. 2. Thermal degradation.
A. Courts (1954)
10.1016/J.IJPHARM.2005.11.040
Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
K. Gao (2006)
10.1383/SURG.21.11.277.22293
Principles of cancer treatment by immunotherapy
L. Durrant (2003)
10.1016/0378-5173(95)04103-6
Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method
J. M. Irache (1995)
10.1016/J.JDERMSCI.2006.12.011
Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
T. Hwang (2007)
10.1016/1011-1344(96)07342-3
Photodynamic therapy: a promising new modality for the treatment of cancer.
J. J. Schuitmaker (1996)
10.1016/J.ADDR.2005.01.021
Optical imaging in drug discovery and diagnostic applications.
K. Licha (2005)
10.1016/S0005-2736(97)00177-6
Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.
G. Cevc (1998)
Nanoparticles in drug delivery.
S. J. Douglas (1987)
10.1081/DDC-120003853
Alginate in Drug Delivery Systems
H. Tønnesen (2002)
10.1021/JA039895G
Synthesis of gold nanoparticles modified with ionic liquid based on the imidazolium cation.
H. Itoh (2004)
10.1021/NL0479987
Super pH-sensitive multifunctional polymeric micelle.
E. Lee (2005)
10.1124/pr.57.2.6
New Approaches and Therapeutics Targeting Apoptosis in Disease
U. Fischer (2005)
Preparation and characterization of glucose-sensitive P(MAA-g-EG) hydrogels
Christie M. Dorski (1997)
10.1021/JA972332I
One-Pot Colorimetric Differentiation of Polynucleotides with Single Base Imperfections Using Gold Nanoparticle Probes
J. Storhoff (1998)
10.1016/S0092-8674(00)80564-4
Cell Death in Development
D. Vaux (1999)
10.1021/CR030698+
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.
M. Daniel (2004)
10.1016/S0091-679X(08)61583-6
Measurement of cell death.
D. T. Loo (1998)
10.1016/S0891-5849(99)00107-0
Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.
Hongshun Wang (1999)
10.1016/j.ejps.2008.01.015
Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
D. Mishra (2008)
10.3109/02652040309178075
Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery
T. K. De (2003)
10.1080/03639040802071661
Aquasomes—A Nanoparticulate Approach for the Delivery of Antigen
A. Goyal (2008)
10.1158/0008-5472.CAN-06-4444
Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors.
M. Dreher (2007)
10.1021/BC000040S
Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes.
K. Licha (2001)
10.1016/S0928-0987(00)00081-6
Preparation and characterization of solid lipid nanospheres containing paclitaxel.
R. Cavalli (2000)
10.1016/S0168-3659(99)00248-5
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H. Maeda (2000)
10.1016/j.ijpharm.2008.07.006
Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
E. Munnier (2008)
10.1042/BJ0580070
The N-terminal amino acid residues of gelatin. 1. Intact gelatins.
A. Courts (1954)
10.1007/s00395-008-0702-7
Near-infrared fluorescent probes for imaging vascular pathophysiology
J. Klohs (2008)
10.1080/00223638.1994.11738594
Photographic Printing in Colloidal Gold
M. Ware (1993)
10.1023/A:1023290514575
Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability
C. Giannavola (2004)
10.1016/J.BBAGEN.2007.01.012
Enhanced cellular delivery and transfection efficiency of plasmid DNA using positively charged biocompatible colloidal gold nanoparticles.
S. Noh (2007)
10.1038/sj.cr.7290194
Mortalin imaging in normal and cancer cells with quantum dot immuno-conjugates
Z. Kaul (2003)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.1021/JS9700661
Pharmaceutical processing with supercritical carbon dioxide.
B. Subramaniam (1997)
10.1002/1521-4095(200108)13:16<1256::AID-ADMA1256>3.0.CO;2-B
Controlled Surface‐Initiated Polymerizations in Aqueous Media
Darren M. Jones (2001)
10.1126/science.1125559
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
N. Rosi (2006)
10.1021/LA036365P
Polymer size and concentration effects on the size of gold nanoparticles capped by polymeric thiols.
Robert G. Shimmin (2004)
Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.
M. Yokoyama (1990)
10.1211/0022357021701
Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells
Jithan V. Aukunuru (2003)
The theory of high-pressure homogenization
S. Jahnke (2001)
10.1002/JPS.20995
Microemulsions--modern colloidal carrier for dermal and transdermal drug delivery.
Sandra Heuschkel (2008)
10.1073/pnas.0608582104
Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
T. Cedervall (2007)
10.1021/BC049962B
Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport.
Seungpyo Hong (2004)
10.1208/pt060480
Liposomal dry powders as aerosols for pulmonary delivery of proteins
D. Lu (2008)
10.1021/MA970660X
Synthesis of Poly(styrene) Monolayers Attached to High Surface Area Silica Gels through Self-Assembled Monolayers of Azo Initiators
O. Prucker (1998)
10.1038/sj.bjp.0704343
Role of von Willebrand factor in tumour cell‐induced platelet aggregation: differential regulation by NO and prostacyclin
P. Jurasz (2001)
10.1021/LA052822L
Didodecyldimethylammonium bromide lipid bilayer-protected gold nanoparticles: synthesis, characterization, and self-assembly.
Lixue Zhang (2006)
10.1021/IE00019A022
Solubility of naproxen in supercritical carbon dioxide with and without cosolvents
S. T. Ting (1993)
10.1038/nm.1727
Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer
J. Burton (2008)
10.1007/978-1-59259-993-6_10
Laser capture microdissection.
M. Emmert-Buck (1996)
10.1002/jps.21603
Poly(amidoamine) dendrimers as skin penetration enhancers: Influence of charge, generation, and concentration.
V. V. Venuganti (2009)
10.1016/J.IJPHARM.2004.10.003
Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles.
M. S. Mesiha (2005)
10.1111/j.1600-079X.2008.00651.x
Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage
R. Rezzani (2009)
10.1021/BM0607776
Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Yu-Hsin Lin (2007)
10.1016/j.jconrel.2008.01.013
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Kyung Hyun Min (2008)
10.1002/JPS.2600521210
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.
T. Higuchi (1963)
10.1021/JA057712F
Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging.
K. Kim (2006)
10.1088/0957-4484/19/44/445103
Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy.
Zu-Yong Wang (2008)
10.1016/J.ADDR.2003.10.028
Lipid vesicles and other colloids as drug carriers on the skin.
G. Cevc (2004)
10.1016/S0168-3659(01)00407-2
Chitosan-based nanoparticles for topical genetic immunization.
Z. Cui (2001)
10.1208/aapsj0901009
Nonviral gene delivery: What we know and what is next
X. Gao (2008)
10.1016/S1359-6446(03)02610-2
Rational design and engineering of therapeutic proteins.
S. A. Marshall (2003)
10.1016/J.ADDR.2007.04.012
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
R. Mueller (2007)
10.1016/J.EJPB.2004.11.002
Novel nanoparticulate carrier system based on carnauba wax and decyl oleate for the dispersion of inorganic sunscreens in aqueous media.
J. R. Villalobos-Hernández (2005)
10.1002/jps.21270
Nanovehicular intracellular delivery systems.
A. Prokop (2008)
10.1161/CIRCULATIONAHA.107.741181
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
M. Nahrendorf (2008)
10.1016/j.jconrel.2007.12.018
Potential of solid lipid nanoparticles in brain targeting.
I. P. Kaur (2008)
10.1021/BI061959N
Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis.
K. Bullok (2007)
10.1016/J.ADDR.2007.04.011
Solid lipid nanoparticles for targeted brain drug delivery.
P. Blasi (2007)
10.1016/J.IJPHARM.2007.10.014
Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Jiesheng Ye (2008)
10.1016/0005-2736(95)00237-5
Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis.
W. Liang (1996)
10.1016/S0378-5173(01)00810-9
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol.
R. Agarwal (2001)
10.1021/ac9809940
Colloidal Au-enhanced surface plasmon resonance immunosensing.
L. A. Lyon (1998)
10.1002/MED.20092
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities
S. Mocellin (2007)
10.2174/157341306775473791
Liposomes as Vehicles for Enhancing Drug Delivery Via Skin Routes
Jia-You Fang (2006)
10.1021/AC026212R
Electrochemical genosensor based on colloidal gold nanoparticles for the detection of Factor V Leiden mutation using disposable pencil graphite electrodes.
M. Ozsoz (2003)
10.1093/TOXSCI/KFJ197
Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells.
C. Sayes (2006)
10.1016/J.JCONREL.2004.01.002
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
M. Oyewumi (2004)
10.1166/JBN.2008.334
Inhaled Liposomes–Current Strategies and Future Challenges
M. Gaspar (2008)
10.1126/SCIENCE.1062711
Nanowire Nanosensors for Highly Sensitive and Selective Detection of Biological and Chemical Species
Yunlong Cui (2001)
10.1361/105994906X113705
Plasma synthesis of carbon-iron magnetic nanoparticles and immobilization of doxorubicin for targeted drug delivery
Y. Ma (2004)
10.1016/J.WATRES.2006.08.004
Comparative eco-toxicity of nanoscale TiO2, SiO2, and ZnO water suspensions.
L. K. Adams (2006)
10.1016/J.AB.2004.06.035
Novel potentiometric immunosensor for hepatitis B surface antigen using a gold nanoparticle-based biomolecular immobilization method.
D. Tang (2004)
10.1016/S0378-5173(02)00080-7
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.
R. Cavalli (2002)
10.1177/153303460400300104
Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer
C. Loo (2004)
10.1002/jps.21358
Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.
D. Drummond (2008)
10.1016/J.CANLET.2005.07.035
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles.
I. El-Sayed (2006)
10.1021/AC0262210
A whole blood immunoassay using gold nanoshells.
L. R. Hirsch (2003)
10.1289/ehp.7021
Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass
E. Oberdörster (2004)
DNAzymes as potential therapeutic molecules.
Y. Isaka (2007)
10.1016/J.IJPHARM.2005.05.027
Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery.
R. Pandey (2005)
10.1016/0378-5173(93)90213-Y
Liposomal l-asparaginase: in vitro evaluation
M. E. Cruz (1993)
10.1016/J.CBPA.2003.08.007
In vivo near-infrared fluorescence imaging.
J. V. Frangioni (2003)
10.2165/00003088-200342050-00004
Transdermal Drug Delivery of Insulin with Ultradeformable Carriers
G. Cevc (2003)
10.1016/S0168-3659(98)00161-8
Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice.
S. C. Chattaraj (1999)
10.2174/1389201053167158
The impact of nanobiotechnology on the development of new drug delivery systems.
O. Kayser (2005)
10.1007/3-540-36583-4_14
Mass vaccination: solutions in the skin.
G. Glenn (2006)
10.1002/jps.21148
Preparation and Evaluation of Poly-Butylcyanoacrylate Nanoparticles for Oral Delivery of Thymopentin
Weiling He (2008)
10.1016/J.BBRC.2005.11.025
NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method.
Henry Ogbomo (2006)
10.2174/0929867043455909
Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.
S. Feng (2004)
10.1002/(SICI)1521-4095(199805)10:8<596::AID-ADMA596>3.0.CO;2-Y
Synthesis of Monodisperse Gold Nanoparticles Using Linear Polymers as Protective Agents
T. Teranishi (1998)
10.1016/S0939-6411(02)00165-0
Pharmaceutical biotechnology products approved within the European Union.
G. Walsh (2003)
10.1016/S0076-6879(05)91022-7
Liposomal superoxide dismutases and their use in the treatment of experimental arthritis.
M. E. Cruz (2005)
Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
M. M. Elsayed (2007)
10.1002/ANIE.200600214
Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles.
G. Han (2006)
10.1023/A:1012142204132
The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres
O. Johnson (2004)
10.1023/A:1016276329672
Polymeric Microspheres Prepared by Spraying into Compressed Carbon Dioxide
R. Bodmeier (2004)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
10.1080/02652040500435444
Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics
J. Yang (2006)
10.1002/mds.20054
Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's disease
L. Priano (2004)
10.1016/J.IJPHARM.2007.09.024
Ligand based dendritic systems for tumor targeting.
A. Agarwal (2008)
10.1126/SCIENCE.291.5507.1363
Worth Its Weight in Gold
M. Bendayan (2001)
10.1021/MA052001N
A Facile Route to Poly(acrylic Acid) Brushes Using Atom Transfer Radical Polymerization
Neil D. Treat (2006)
10.1016/S0163-7827(03)00032-8
Ligand-targeted liposomal anticancer drugs.
P. Sapra (2003)
10.1021/BM060030F
Chitosan-mediated synthesis of gold nanoparticles on patterned poly(dimethylsiloxane) surfaces.
B. Wang (2006)
10.1016/S1470-2045(06)70793-8
Emerging use of nanoparticles in diagnosis and treatment of breast cancer.
M. Yezhelyev (2006)
10.1038/nbt720
Magnetic relaxation switches capable of sensing molecular interactions
J. M. Pérez (2002)
10.1038/SJ.JID.5700323
Innovative liposomes as a transfollicular drug delivery system: penetration into porcine hair follicles.
S. Jung (2006)
10.1016/J.NANO.2007.10.051
Cell-Surface Interactions Studies to Trigger Stem Cell Differentiation
E. Martínez (2007)
10.1007/978-0-387-85600-1_20
APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE
C. Bárcena (2003)
Industrial applications of microemulsions
C. Solans (1997)
10.1002/ADFM.200305139
Poled sol-gel materials with heterocycle push-pull chromophores that confer enhanced second-order optical nonlinearity
G. Brusatin (2004)
10.1016/S1470-2045(02)00818-5
Hyperthermia in combined treatment of cancer.
P. Wust (2002)
10.2174/156720106775197574
Topical DermaVir vaccine targeting dendritic cells.
J. Lisziewicz (2006)
10.1038/nrc1958
Polymer conjugates as anticancer nanomedicines
R. Duncan (2006)
10.1016/J.NANO.2005.06.004
Role of nanotechnology in targeted drug delivery and imaging: a concise review.
O. Koo (2005)
10.1016/S0939-6411(03)00143-7
Lecithin vesicles for topical delivery of diclofenac.
R. Boinpally (2003)
10.1021/MA9610626
Synthesis and Erosion Studies of Self-Catalyzed Poly(ortho ester)s
S. Ng (1997)
10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
Design of folic acid-conjugated nanoparticles for drug targeting.
B. Stella (2000)
10.1615/CRITREVTHERDRUGCARRIERSYST.V13.I3-4.30
Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery.
G. Cevc (1996)
10.1002/ANIE.199001381
Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter
D. Tomalia (1990)
10.2217/17435889.3.4.579
Silica-based multimodal/multifunctional nanoparticles for bioimaging and biosensing applications.
Padmavathy Tallury (2008)
Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood.
M. Yokoyama (1991)
10.2174/1874104500802010062
A New Concept for Smart Drug Delivery: Adhesion Induced Nanovector Implosion§
N. Pugno (2008)
10.1016/J.JCONREL.2005.06.002
Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.
S. Vinogradov (2005)
10.1021/JP036522T
Size-Dependent Phase Transfer of Gold Nanoparticles from Water into Toluene by Tetraoctylammonium Cations: A Wholly Electrostatic Interaction
W. Cheng (2004)
10.1016/S0928-0987(98)00037-2
Liposome-skin interactions and their effects on the skin permeation of drugs.
M. Kirjavainen (1999)
10.1074/jbc.272.9.5487
Tumor Necrosis Factor α Enhances the Expression of the Interleukin (IL)-4 Receptor α-Chain on Endothelial Cells Increasing IL-4 or IL-13-induced Stat6 Activation*
S. Lugli (1997)
10.1002/JBM.820190920
Glucose-sensitive membranes containing glucose oxidase: activity, swelling, and permeability studies.
J. Kost (1985)
10.1007/s00330-002-1524-x
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging
V. Ntziachristos (2002)
10.2131/JTS.27.229
Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines.
K. Wang (2002)
10.1021/LA0633841
Water-soluble nitric oxide-releasing gold nanoparticles.
M. A. Polizzi (2007)
10.1016/0022-1759(86)90393-5
An enzyme-linked immunosorbent assay for the detection of autoantibodies to albumin.
D. Sansonno (1986)
10.1016/0022-1759(83)90438-6
An enzyme-release assay for natural cytotoxicity.
C. Korzeniewski (1983)
10.1016/S0378-5173(01)00923-1
Characterization of nanoparticle uptake by endothelial cells.
J. Davda (2002)
10.1016/J.JCONREL.2004.11.020
Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.
C. Sinico (2005)
10.1002/AIC.690390113
Polymeric materials formed by precipitation with a compressed fluid antisolvent
D. Dixon (1993)
10.1021/JA983183M
Nanometer Gold Clusters Protected by Surface-Bound Monolayers of Thiolated Poly(ethylene glycol) Polymer Electrolyte
W. Wuelfing (1998)
10.1002/ANIE.200503873
Materials for fluorescence resonance energy transfer analysis: beyond traditional donor-acceptor combinations.
K. Sapsford (2006)
10.1081/DIS-120021794
Surface Initiated Polymerization from Nanoparticle Surfaces
R. Advincula (2003)
10.1023/A:1018965121222
Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes
H. Harashima (2004)
10.1016/0378-5173(92)90348-6
Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation
M. Morishita (1992)
10.1023/A:1018908421434
Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release
H. Yoo (2004)
10.1016/J.JCONREL.2004.07.032
Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.
Soo-Jeong Lim (2004)
10.1016/J.IJPHARM.2004.07.039
Investigation of liposomes as carriers of sodium ascorbyl phosphate for cutaneous photoprotection.
Alma Foco (2005)
10.1002/DDR.20066
Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors
G. Paciotti (2006)
10.1016/S0168-3659(03)00326-2
Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid.
Ebtessam A. Essa (2003)
Practical Flow Cytometry
H. Shapiro (1985)
10.1016/S0168-3659(01)00399-6
Sustained release ketoprofen microparticles with ethylcellulose and carboxymethylethylcellulose.
T. Yamada (2001)
10.1016/J.BBRC.2007.11.153
Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier.
T. Yoshikawa (2008)
10.1016/0022-1759(90)90331-O
Liposomes in the therapy of infectious diseases and cancer: Lopez-Berestein, G. and Fidler, I.J. (Eds.), 500 pp. Alan R. Liss, New York, 1989. USD 96.00, ISBN 0-8451-2688-1
F. Borek (1990)
10.1016/0305-7372(95)90037-3
Late effects of treatment in long-term survivors of cancer.
C. Schwartz (1995)
10.1002/JPS.20873
Hydrogels for tissue engineering and delivery of tissue-inducing substances.
B. Baroli (2007)
10.1089/HUM.1998.9.12-1709
Controlled gene delivery by DNA-gelatin nanospheres.
V. L. Truong-Le (1998)
10.1201/9781420008449.CH14
Lipid Nanoparticles (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers) for Cosmetic, Dermal, and Transdermal Applications
E. Souto (2007)
10.1007/BF03215512
The weird world of nanoscale gold
M. Cortie (2004)
10.1002/jgm.1060
Structural and transfection properties of amine‐substituted gemini surfactant‐based nanoparticles
S. Wettig (2007)
10.1016/J.JCONREL.2007.03.006
Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
M. Bhavsar (2007)
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
Melike Üner (2007)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1021/JP045070X
Light-responsive polyelectrolyte/gold nanoparticle microcapsules.
A. S. Angelatos (2005)
Preparation of liposomes
G. Gregoriadis (1984)
10.1016/S0955-2219(96)00224-5
Synthesis and properties of ceramic nanoparticles and nanocomposites
D. Vollath (1997)
10.1073/pnas.2232479100
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
L. R. Hirsch (2003)
10.1557/PROC-394-155
Aspects of Polymer Erosion
A. Göpferich (1995)
10.1002/MARC.1983.030040511
Control of insulin permeation through a polymer membrane with responsive function for glucose
K. Ishihara (1983)
10.1016/0378-5173(91)90361-Q
In vitro permeation of azelaic acid from viscosized microemulsions
M. Gasco (1991)
10.1016/J.JCONREL.2003.12.020
Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery.
J. Park (2004)
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
F. Yuan (1995)
10.1080/10611860600935701
Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice
Gee Young Lee (2006)
10.1021/JA057056J
Aggregation-induced folding of a de novo designed polypeptide immobilized on gold nanoparticles.
D. Aili (2006)
10.1021/JA0654377
Multicomponent polymer brushes.
F. Zhou (2006)
10.1081/DIS-100102681
Characterization of Microcapsules of β-Lactoglobulin Formed by Chemical Cross Linking and Heat Setting
Chaitali Bhattacharjee (2001)
10.1016/J.IJPHARM.2007.03.028
Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
L. Yang (2007)
10.1021/MA001615J
Nanocomposites by Surface-Initiated Living Cationic Polymerization of 2-Oxazolines on Functionalized Gold Nanoparticles
R. Jordan (2001)
10.1021/MA060739E
Synthesis of poly(methacrylic acid) brushes via surface-initiated atom transfer radical polymerization of sodium methacrylate and their use as substrates for the mineralization of calcium carbonate
Stefano Tugulu (2007)
10.1016/J.TOXLET.2005.07.005
In vitro study of the pulmonary translocation of nanoparticles: a preliminary study.
J. Geys (2006)
10.1016/S0168-3659(99)00222-9
Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.
E. Touitou (2000)
10.1016/j.jconrel.2008.09.086
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
F. Danhier (2009)
10.1002/JCTB.5000660808
Heat degradation of gelatin
W. M. Ames (1947)
10.1016/S0169-409X(02)00114-X
Skin structure and mode of action of vesicles.
J. Bouwstra (2002)
10.1055/S-0037-1614906
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.
C. Fernandez-Patron (1999)
10.1016/S0169-409X(00)00058-2
Endothelial cell delivery for cardiovascular therapy.
S. Parikh (2000)
10.1002/ART.20379
In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response.
A. Wunder (2004)
10.1002/MABI.200700165
A nanoparticulate drug-delivery system for rivastigmine: physico-chemical and in vitro biological characterization.
E. Craparo (2008)
Inhalable drugs for systemic therapy.
K. Corkery (2000)
10.1023/A:1018873702411
Inhibition of Multidrug Resistance-Associated Protein (MRP) Functional Activity with Pluronic Block Copolymers
D. Miller (2004)
10.1038/PHYSCI241020A0
Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions
G. Frens (1973)
10.1016/J.BIOS.2004.07.029
Electrochemically deposited chitosan hydrogel for horseradish peroxidase immobilization through gold nanoparticles self-assembly.
X. Luo (2005)
10.1007/S10856-007-3010-0
Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels
J. Liu (2007)
10.1208/pt050452
Characterization of reservoir-type microcapsules made by the solvent exchange method
Y. Yeo (2008)
10.1021/JA001215B
Colloidal Au-Enhanced Surface Plasmon Resonance for Ultrasensitive Detection of DNA Hybridization
L. He (2000)
10.1016/S0140-6736(74)90682-5
Drug-carrier potential of liposomes in cancer chemotherapy.
G. Gregoriadis (1974)
10.1016/0168-3659(93)90037-6
Mathematical analysis of drug release from a coated particle
S. M. Lu (1993)
10.1021/MA00099A035
Dynamic contact angle measurement of temperature-responsive surface properties for poly(N-isopropylacrylamide) grafted surfaces
Yoshiyuki G. Takei (1994)
10.1021/LA0355848
Size-selective synthesis of gold and platinum nanoparticles using novel thiol-functionalized ionic liquids.
K. Kim (2004)
10.1016/S0378-4274(97)00071-4
Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60.
Tzuu-Huei Ueng (1997)
10.1016/S0168-3659(99)00108-X
Preparation and properties of glutaraldehyde cross-linked whey protein-based microcapsules containing theophylline.
S. Lee (1999)
10.1148/RADIOL.2212010368
Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.
C. Bremer (2001)
10.1002/jps.21221
Antitumor effect of all-trans retinoic acid-encapsulated nanoparticles of methoxy poly(ethylene glycol)-conjugated chitosan against CT-26 colon carcinoma in vitro.
Jung-Sun Park (2008)
10.1016/0049-3848(83)90230-X
An improved method for washing of human platelets with prostacyclin.
M. Radomski (1983)
10.1002/JPS.21079
Dendrimers as drug carriers: applications in different routes of drug administration.
Y. Cheng (2008)
Drug delivery to the brain using polymers.
A. Domb (1991)
10.1002/POLA.21195
Homopolymer and Block Copolymer Brushes on Gold by Living Anionic Surface-Initiated Polymerization in a Polar Solvent
G. Sakellariou (2006)
10.1136/gut.2005.090498
Oral proteases: a new approach to managing coeliac disease
N. Cerf-Bensussan (2007)
10.1016/J.COLSURFB.2007.05.011
Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid.
M. Stevanović (2007)
10.1016/j.ijpharm.2008.01.008
Solid lipid nanoparticles for pulmonary delivery of insulin.
J. Liu (2008)
10.1080/10611860400013451
Biodistribution and Targeting Potential of Poly(ethylene glycol)-modified Gelatin Nanoparticles in Subcutaneous Murine Tumor Model
Goldie Kaul (2004)
10.1007/s11095-007-9439-5
Nonviral Approaches for Neuronal Delivery of Nucleic Acids
J. Bergen (2007)
Investigations on the occlusive properties of solid lipid nanoparticles (SLN).
S. Wissing (2001)
10.1002/JPS.21249
Magnetic colloids as drug vehicles.
J. D. Durán (2008)
10.1148/RADIOL.2223010812
Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes.
C. Bremer (2002)
10.1016/J.BIOMATERIALS.2005.02.038
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
N. Dinauer (2005)
10.1016/0168-3659(85)90057-4
Ocular therapy with nanoparticulate systems for controlled drug delivery
R. Gurny (1985)
10.3109/02652049109069563
Effect of nanoparticles on transdermal drug delivery.
M. J. Cappel (1991)
10.1080/10408440601177780
Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety
G. Nohynek (2007)
Human serum albumin nanoparticles for efficient delivery of Cu, Zn superoxide dismutase gene
Y. Mo (2007)
10.1021/JA015556G
Inhibition of DNA transcription using cationic mixed monolayer protected gold clusters.
C. M. McIntosh (2001)
10.1016/j.jconrel.2007.11.014
Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles.
Haiqing Yin (2008)
10.1016/S0168-3659(02)00051-2
Topical immunization using nanoengineered genetic vaccines.
Z. Cui (2002)
10.1002/JBM.820230209
Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
R. Tamargo (1989)
10.1016/J.JBIOTEC.2006.06.012
Use of whey protein beads as a new carrier system for recombinant yeasts in human digestive tract.
G. Hébrard (2006)
10.1016/S0002-9610(03)00212-5
Targeted therapies for the treatment of cancer.
J. Kim (2003)
10.1021/JA02086A003
The rate of solution of solid substances in their own solutions
A. A. Noyes (1897)
10.1080/07388550601173926
L-Asparaginase: A Promising Chemotherapeutic Agent
N. Verma (2007)
10.1016/S0169-409X(02)00179-5
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities.
G. Saito (2003)
10.1016/S1359-6446(03)02903-9
Nanotech approaches to drug delivery and imaging.
S. Sahoo (2003)
10.1586/14737159.7.5.647
Laser capture microdissection technology
V. Espina (2007)
10.1002/0471143030.cb1805s19
Analysis of Mitochondrial Dysfunction During Cell Death
V. Gogvadze (2003)
10.1016/S0140-6736(62)90632-3
Tissue reactions to polymers.
K. Little (1962)
The North and South Poles
P. Kitson (2001)
10.1016/0268-960X(90)90047-V
Effects of chemotherapy on fertility.
C. Barton (1990)
10.1016/0378-5173(89)90154-3
Microencapsulation of peptide: a study of the phase separation of poly(d,l-lactic acid-co-glycolic acid) copolymers 50/50 by silicone oil
J. M. Ruiz (1989)
10.1021/LA048328J
Gold nanoparticle embedded, self-sustained chitosan films as substrates for surface-enhanced Raman scattering.
D. S. dos Santos (2004)
10.1021/JA046572R
Tunable reactivation of nanoparticle-inhibited beta-galactosidase by glutathione at intracellular concentrations.
A. Verma (2004)
10.1002/ADMA.200400920
Optically Addressable Nanostructured Capsules
B. Radt (2004)
10.1021/JA981348L
Surface-Initiated Anionic Polymerization of Styrene by Means of Self-Assembled Monolayers
R. Jordan (1999)
10.1016/j.jsbmb.2004.12.023
Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma
S. Maillard (2005)
10.1126/SCIENCE.2218494
New methods of drug delivery.
R. Langer (1990)
10.1002/DDR.10157
Biopolymer albumin for diagnosis and in drug delivery
G. V. Patil (2003)
10.1016/J.FUPROC.2004.03.006
Preparation of carbon-coated magnetic iron nanoparticles from composite rods made from coal and iron powders
J. Qiu (2004)
10.1002/JBM.820190408
The intracellular degradation of poly(ε-caprolactone)
S. C. Woodward (1985)
10.1016/S0378-5173(03)00134-0
Optimization of the preparation process for human serum albumin (HSA) nanoparticles.
K. Langer (2003)
10.1016/J.JBBM.2006.09.007
Amperometric hydrogen peroxide biosensor based on the immobilization of HRP on nano-Au/Thi/poly (p-aminobenzene sulfonic acid)-modified glassy carbon electrode.
Fengxian Gao (2007)
10.1016/J.CANLET.2004.02.004
Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles.
D. O'Neal (2004)
10.1002/ijc.22296
Aclarubicin‐loaded cationic albumin‐conjugated pegylated nanoparticle for glioma chemotherapy in rats
W. Lu (2007)
10.1211/002235702289
Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix)
S. Babiuk (2002)
10.1016/S1074-7613(02)00275-3
Arthritis critically dependent on innate immune system players.
H. Ji (2002)
10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z
In vivo imaging of extracellular pH using 1H MRSI
R. van Sluis (1999)
10.1016/S0939-6411(97)00056-8
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
M. D. Blanco (1997)
10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6
Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.
M. Lück (1998)
10.1038/nrd1632
Recent advances with liposomes as pharmaceutical carriers
V. Torchilin (2005)
10.1016/j.jconrel.2008.03.019
A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides.
Kyeongsoon Park (2008)
10.1016/S0926-6690(00)00064-9
Zein: the industrial protein from corn
R. Shukla (2001)
10.7150/IJBS.3.108
Application of Nanotechnology in Cancer Research: Review of Progress in the National Cancer Institute's Alliance for Nanotechnology
B. Ehdaie (2007)
10.1023/A:1012104017761
Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation
K. Thode (2004)
10.1007/s11095-006-0284-8
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
10.3748/WJG.V11.I33.5136
In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells.
Li-feng Qi (2005)
10.1080/10611860400015936
Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
P. Lockman (2004)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.1007/BF02980228
Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles
Qing-yu Xiang (2007)
10.1007/S00216-006-0375-8
Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples
Imam H. Shaik (2006)
10.1016/S0065-3233(08)60640-3
Structure of serum albumin.
D. Carter (1994)
10.1016/J.EJPHAR.2004.06.054
Current strategies in cancer gene therapy.
Anas El-Aneed (2004)
10.1038/nbt1306
Decoding global gene expression programs in liver cancer by noninvasive imaging
E. Segal (2007)
10.1016/J.TETLET.2005.03.081
An octa-cationic core-shell dendrimer as a molecular template for the assembly of anionic fullerene derivatives
R. V. D. Coevering (2005)
10.1016/S0168-3659(02)00321-8
Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways.
S. Mitragotri (2003)
10.1021/LA991040N
Spontaneous Formation of Gold Nanoparticles in Aqueous Solution of Sugar-Persubstituted Poly(amidoamine)dendrimers
K. Esumi (2000)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
10.1016/S0169-409X(02)00118-7
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
R. Mueller (2002)
10.1002/JPS.21177
Biocompatible microemulsions and their prospective uses in drug delivery.
S. Gupta (2008)
10.1109/MEMSYS.2001.906566
A high-performance silicon micropump for disposable drug delivery systems
D. Maillefer (2001)
10.1080/026520400288427
Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.
C. Coester (2000)
10.1161/01.ATV.0000033089.56970.2D
In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe
F. Jaffer (2002)
10.1096/fj.04-2747rev
Nanomedicine: current status and future prospects
S. Moghimi (2005)
10.1023/B:PHAM.0000003374.58641.62
In Situ Blood–Brain Barrier Transport of Nanoparticles
J. Koziara (2004)
10.1158/1078-0432.CCR-07-1441
Therapeutic Nanoparticles for Drug Delivery in Cancer
Kwangjae Cho (2008)
10.1023/A:1011042627714
Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles
H. Bunjes (2004)
10.1186/1477-3155-2-3
Applications of nanoparticles in biology and medicine
OV Salata (2004)
10.1080/02652040500162378
A novel approach based on lipid nanoparticles (SLN®) for topical delivery of α-lipoic acid
E. Souto (2005)
10.1021/BC015545C
Gold nanoparticle-mediated transfection of mammalian cells.
Kulmeet K Sandhu (2002)
10.1096/fj.00-0022com
Cell‐selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting
A. Scherpereel (2001)
10.1016/0142-9612(80)90060-5
Controlled release of biologically active compounds from bioerodible polymers.
J. Heller (1980)
10.1016/S0264-410X(98)00488-5
DNA-based non-invasive vaccination onto the skin.
Z. Shi (1999)
10.3109/10611869308996081
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method.
W. Lin (1993)
10.25011/CIM.V31I3.3473
Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles.
X. Zhang (2008)
10.1016/J.PLIPRES.2003.10.001
Lipid peroxidation cannot be used as a universal criterion of oxidative stress.
Y. Dotan (2004)
10.1016/J.IJPHARM.2007.05.060
Nanostructured lipid carrier (NLC) based gel of celecoxib.
M. Joshi (2008)
10.1016/J.COPBIO.2007.01.003
Fluorescence imaging in vivo: recent advances.
J. Rao (2007)
10.1016/S0006-291X(02)00445-X
Cellular localisation of a water-soluble fullerene derivative.
Sarah Foley (2002)
10.1038/86684
A clearer vision for in vivo imaging
R. Weissleder (2001)
10.1007/s11095-007-9257-9
Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin
D. Bhumkar (2007)
10.1016/S0378-5173(00)00623-2
Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.
A. Lippacher (2001)
10.1021/NL062395B
Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells.
J. Green (2007)
10.1211/0022357991776813
Skin Delivery of Oestradiol from Deformable and Traditiona Liposomes: Mechanistic Studies
Gamal M. M. El Maghraby (1999)
10.1021/JA056726I
Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers.
Rui Hong (2006)
10.1021/MA070176M
Hyperbranched Polymers Analogous to PAMAM Dendrimers for the Formation and Stabilization of Gold Nanoparticles
N. Perignon (2007)
10.1158/1078-0432.CCR-07-1958
Imaging Epidermal Growth Factor Receptor Expression In vivo: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
P. Diagaradjane (2008)
10.1021/BM060815L
Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells.
A. Myc (2007)
10.1211/jpp.58.3.0003
Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in‐vitro and in‐vivo characterization
S. Jain (2006)
10.1002/ELPS.200305690
Alternative sample preparation prior to two‐dimensional electrophoresis protein analysis on solid lipid nanoparticles
T. Göppert (2004)
10.1038/sj.bjp.0704345
Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets
A. Radomski (2001)
10.1021/JA075181K
Paclitaxel-functionalized gold nanoparticles.
J. Gibson (2007)
10.2174/1389450013348245
Gene therapy: optimising DNA delivery to the nucleus.
M. Johnson-Saliba (2001)
10.1161/CIRCULATIONAHA.106.660340
Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor
F. Jaffer (2007)
10.1016/J.CHEMBIOL.2005.09.008
Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death.
Jasmina Lovrić (2005)
10.2174/0929867054546663
Drug-associated mitochondrial toxicity and its detection.
D. Amacher (2005)
10.1016/S0378-5173(03)00055-3
Insulin containing polyethylenimine-dextran sulfate nanoparticles.
W. Tiyaboonchai (2003)
10.1111/j.1582-4934.2008.00189.x
Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis
Hai-yan Hong (2008)
10.1038/89126
In vivo molecular target assessment of matrix metalloproteinase inhibition
C. Bremer (2001)
10.1016/J.ACA.2003.12.067
Modification of Escherichia coli single-stranded DNA binding protein with gold nanoparticles for electrochemical detection of DNA hybridization
K. Kerman (2004)
10.1016/J.ADDR.2004.02.014
Nanoparticle and targeted systems for cancer therapy.
L. Brannon-Peppas (2004)
10.1016/j.jconrel.2008.04.024
Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance.
E. Lee (2008)
10.1073/PNAS.96.9.5182
In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.
D. W. Cagle (1999)
10.1016/J.IJPHARM.2004.09.022
Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: interference by colloidal tin oxide particles.
Tanima Banerjee (2005)
10.1080/1061186031000086108
In Vitro and In Vivo Study of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide
E. Peira (2003)
10.1016/J.IJPHARM.2003.12.016
Preparation and characterization of solid lipid nanoparticles containing peptide.
F. Hu (2004)
10.1016/J.EJCA.2005.02.017
Use of angiogenesis inhibitors in tumour treatment.
J. Fayette (2005)
10.1126/SCIENCE.289.5485.1757
Scanometric DNA array detection with nanoparticle probes.
T. Taton (2000)
10.1002/JBM.A.31372
Delivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticles.
X. Xu (2008)
10.1166/JNN.2007.809
Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.
L. Priano (2007)
10.1016/S1011-1344(02)00320-2
Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells.
F. Rancan (2002)
10.1016/S0002-9610(02)00942-X
Laser therapy for small breast cancers.
K. Dowlatshahi (2002)
10.1016/J.NANO.2006.11.005
Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.
S. Kommareddy (2007)
10.1021/JA0007962
The DNA-Mediated Formation of Supramolecular Mono- and Multilayered Nanoparticle Structures
T. Taton (2000)
10.1016/S0956-5663(03)00252-5
Application of impedance spectroscopy for monitoring colloid Au-enhanced antibody immobilization and antibody-antigen reactions.
M. Wang (2004)
10.1016/J.COLSURFB.2006.09.012
Development and characterization of new insulin containing polysaccharide nanoparticles.
B. Sarmento (2006)
10.1021/bc700356f
A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo.
A. Masotti (2008)
10.1023/A:1015810312465
Predicting Skin Permeability
R. Potts (2004)
10.1038/74480
Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex
A. Domashenko (2000)
10.1211/0022357001777450
Delivery of Lipoplexes for Genotherapy of Solid Tumours: Role of Vascular Endothelial Cells
C. Dass (2000)
10.1016/S0168-3659(01)00530-2
PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties.
K. Avgoustakis (2002)
10.1021/CM049764U
Thermo- and pH-Responsive Hydrogel-Coated Gold Nanoparticles
J. Kim (2004)
Ph
李幼升 (1989)
10.1016/S0378-5173(01)00672-X
Topical transfection using plasmid DNA in a water-in-oil nanoemulsion.
H. Wu (2001)
10.1211/0022357021918
Evidence for lymphatic transport of insulin by topically applied biphasic vesicles
M. King (2003)
10.1016/0002-9149(91)90217-9
Biology of the impaired endothelium.
E. Nabel (1991)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
Polyalkylcyanoacrylates as colloidal drug carriers.
P. Couvreur (1988)
10.1016/S0014-5793(97)01356-2
Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients
R. Dunford (1997)
10.1021/MP060132K
Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model.
Y. Chen (2007)
10.1002/JPS.20813
Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.
S. Kommareddy (2007)
10.1016/S1748-0132(06)70020-2
Nanoparticles in biomolecular detection
N. C. Tansil (2006)
10.1016/j.ejps.2008.07.006
Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier.
Zheyu Shen (2008)
10.1007/BF01733047
Encapsulation of macromolecules by lipid vesicles under simulated prebiotic conditions
D. Deamer (2005)
10.1016/J.IJPHARM.2003.07.015
Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin.
T. Morçöl (2004)
10.1016/0005-2736(92)90154-E
Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force.
G. Cevc (1992)
10.1016/J.JMMM.2004.10.103
Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields
R. Asmatulu (2005)
10.1002/JPS.20673
Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds.
F. S. Nielsen (2007)
10.1021/CM034932O
PREPARATION AND CHARACTERIZATION OF 1?2 NM DENDRIMER-ENCAPSULATED GOLD NANOPARTICLES HAVING VERY NARROW SIZE DISTRIBUTIONS
Y. G. Kim (2004)
10.1108/nfs.2010.01740cab.009
Generally Recognized As Safe
W. Shuey (1971)
10.1021/CR0300789
Self-assembled monolayers of thiolates on metals as a form of nanotechnology.
J. Love (2005)
10.1002/(SICI)1097-4636(199607)31:3<401::AID-JBM15>3.0.CO;2-L
Effect of polymeric nanoparticle administration on the clearance activity of the mononuclear phagocyte system in mice.
R. Fernández-Urrusuno (1996)
10.1016/S0376-7388(99)00062-9
Characterization of micromachined silicon membranes for immunoisolation and bioseparation applications
T. Desai (1999)
10.1016/J.ACA.2006.01.094
Electrochemical immuno-bioanalysis for carcinoma antigen 125 based on thionine and gold nanoparticles-modified carbon paste interface
D. Tang (2006)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1002/JPS.20057
Cyclosporin nanoparticulate lipospheres for oral administration.
Tania Bekerman (2004)
10.1016/S0142-9612(00)00063-6
Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes.
N. Dayan (2000)
Liposome Drug Delivery Systems
G. Betageri (1993)
10.1007/s00726-001-0142-2
Targeting of MPEG-protected polyamino acid carrier to human E-selectin in vitro
H. W. Kang (2002)
10.1016/S0304-4165(02)00415-4
The in vivo and in vitro interactions of elastic and rigid vesicles with human skin.
P. Honeywell-Nguyen (2002)
10.1080/10611860802088598
Long circulating PEGylated poly(d,l-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors
M. Senthilkumar (2008)
10.1038/nnano.2008.34
Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.
E. Tasciotti (2008)
10.1016/S0167-7799(98)01220-7
Novel applications of liposomes.
D. Lasic (1998)
10.1007/S11051-006-9162-X
Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization
Yu-Qing Zhang (2007)
10.1016/j.jconrel.2008.02.003
Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
H. Hwang (2008)
10.1080/10611860310001647771
Receptor Mediated Targeting of Lectin Conjugated Gliadin Nanoparticles in the Treatment of Helicobacter pylori
R. Umamaheshwari (2003)
10.1159/000210920
Topical application of liposomally entrapped cyclosporin evaluated by in vitro diffusion studies with human skin.
K. Egbaria (1991)
10.1023/B:PHAM.0000019291.36636.c1
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Sylvia A. Wissing (2004)
10.1021/LA050656B
Synthesis of tetraoctylammonium-protected gold nanoparticles with improved stability.
Steven R. Isaacs (2005)
10.1016/J.JCONREL.2007.04.004
Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
X. Y. Xiong (2007)
10.1016/S0378-5173(03)00135-2
Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique.
M. Trotta (2003)
Impaired skin barrier function in dermatologic disease and repair with moisturization.
M. Lebwohl (2005)
10.1016/J.TOXLET.2004.08.015
Effect of single wall carbon nanotubes on human HEK293 cells.
D. Cui (2005)
10.1023/A:1018998529283
Hindered Diffusion of Polar Molecules Through and Effective Pore Radii Estimates of Intact and Ethanol Treated Human Epidermal Membrane
K. Peck (2004)
10.1002/jps.21325
Nanodisks derived from amphotericin B lipid complex.
Megan Tufteland (2008)
10.1007/s11095-006-0069-0
Complement Activation by Core–Shell Poly(isobutylcyanoacrylate)–Polysaccharide Nanoparticles: Influences of Surface Morphology, Length, and Type of Polysaccharide
I. Bertholon (2006)
10.1016/j.ijpharm.2008.08.020
Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
B. Gaihre (2009)
10.1002/JPS.20833
Poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as polymeric emulsifier for the preparation of biodegradable nanoparticles.
G. Gaucher (2007)
10.1159/000093119
Hair Follicles – A Long-Term Reservoir for Drug Delivery
J. Lademann (2006)
10.1002/0471220450
Handbook of Radical Polymerization
K. Matyjaszewski (2002)
10.1039/C39940000801
Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system
M. Brust (1994)
10.1088/0957-4484/19/48/485101
Smart nanoprobes for ultrasensitive detection of breast cancer via magnetic resonance imaging.
J. Lee (2008)
10.1161/01.CIR.91.2.541
Gene therapy for cardiovascular disease.
E. Nabel (1995)
10.1016/J.JCONREL.2006.10.023
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
C. Damgé (2007)
10.1016/J.ADDR.2005.09.013
Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kelly M. Kitchens (2005)
Controlled Release of Biologically Active Agents
R. W. Baker (1987)
10.1002/(SICI)1099-0518(19990815)37:16<3337::AID-POLA32>3.0.CO;2-S
Fatty acid terminated polyanhydrides
A. Domb (1999)
10.1016/0167-7799(93)90076-L
Recent advances in drug targeting.
G. Gregoriadis (1993)
10.1021/JA060782H
Amphiphilic gold nanoparticles with V-shaped arms.
E. Zubarev (2006)
10.1146/ANNUREV.BIOENG.9.060906.152025
Nanotechnology applications in cancer.
Shuming Nie (2007)
10.1021/JA973392R
Surface Initiated Living Cationic Polymerization of 2-Oxazolines on Gold Nanoparticles
R. Jordan (1998)
10.1038/86762
Single-mismatch detection using gold-quenched fluorescent oligonucleotides
B. Dubertret (2001)
10.1016/j.drudis.2008.09.005
The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
L. Juillerat-Jeanneret (2008)
10.1080/10611860600648429
Local treatment of experimental colitis in the rat by negatively charged liposomes of catalase, TMN and SOD
T. Jubeh (2006)
10.1023/A:1019842024814
Synthesis of Pegylated Immunonanoparticles
J. Olivier (2004)
10.1016/J.JCONREL.2005.07.024
Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
Celeste A. Roney (2005)
10.1016/j.jconrel.2008.02.007
Design and production of nanoparticles formulated from nano-emulsion templates-a review.
N. Anton (2008)
10.1080/02652040400015346
Characteristics of felodipine-located poly(ε-caprolactone) microspheres
Bum-Keun Kim (2005)
10.1016/J.BIOMATERIALS.2006.05.016
Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells.
I. Steinhauser (2006)
10.1109/MEMB.2004.1337950
Near infrared optical applications in molecular imaging
U. Mahmood (2004)
10.1016/J.JCONREL.2003.11.011
Genetically engineered polymers: status and prospects for controlled release.
M. Haider (2004)
10.1081/CUS-120001859
Mathematical models in percutaneous absorption
M. Roberts (1999)
10.1016/0168-3659(94)00125-E
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate
F. Bonina (1995)
Encyclopedic Handbook of Biomaterials and Bioengineering
D. Wise (1995)
10.1126/SCIENCE.297.5586.1536
Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection.
Y. Cao (2002)
10.1002/EJI.1830251248
Transdermal immunization with large proteins by means of ultradeformable drug carriers
A. Paul (1995)
10.1016/J.BIOS.2005.09.014
Glucose biosensor based on Au nanoparticles-conductive polyaniline nanocomposite.
Y. Xian (2006)
10.1016/S0168-1656(03)00029-4
Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device.
Z. Cui (2003)
10.1211/0022357991772925
Gelatin Behaviour in Dilute Aqueous Solution: Designing a Nanoparticulate Formulation
C. Farrugia (1999)
10.1016/J.BIOMATERIALS.2006.11.004
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
X. Liu (2007)
10.1016/J.JCONREL.2003.08.005
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.
C. Vauthier (2003)
10.1016/J.JCONREL.2006.12.012
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
J. Kreuter (2007)
10.1016/J.JELECHEM.2007.02.004
Electrochemical biosensors based on colloidal gold–carbon nanotubes composite electrodes
J. Manso (2007)
10.1166/JNN.2006.455
Gliadin characterization by SANS and gliadin nanoparticle growth modelization.
A. Orecchioni (2006)
10.1016/S0378-5173(00)00336-7
Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes.
J. Birchall (2000)
10.1016/J.NANO.2006.04.003
An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Jiaofeng Peng (2006)
10.1002/JPS.2600820909
Development of a new drug carrier made from alginate.
M. Rajaonarivony (1993)
10.1016/J.ELECOM.2007.01.007
Biosynthesis of gold nanoparticles assisted by Escherichia coli DH5α and its application on direct electrochemistry of hemoglobin
Liangwei Du (2007)
10.1023/A:1018980020506
The Preparation and Characterization of Poly(lactide-co-glycolide) Microparticles. II. The Entrapment of a Model Protein Using a (Water-in-Oil)-in-Water Emulsion Solvent Evaporation Technique
H. Jeffery (2004)
10.1016/S1079-2104(99)70164-2
A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
E. Horwitz (1999)
10.1016/S0142-9612(01)00052-7
Intracellular delivery mediated by an ethosomal carrier.
E. Touitou (2001)
Liposomes : a practical approach
R. New (1990)
10.1002/ANIE.200461119
Core/Shell gold nanoparticles by self-assembly and crosslinking of micellar, block-copolymer shells.
Y. Kang (2005)
10.4103/0255-0857.37340
Detection of Mycoplasma species in cell culture by PCR and RFLP based method: effect of BM-cyclin to cure infections.
V. Gopalkrishna (2007)
Liposomes: an overview of manufacturing techniques.
M. Mozafari (2005)
10.1016/0885-3924(92)90062-M
Psychological techniques for controlling the adverse side effects of cancer chemotherapy: findings from a decade of research.
T. Burish (1992)
10.1039/DF9511100055
A study of the nucleation and growth processes in the synthesis of colloidal gold
J. Turkevich (1951)
10.1021/BC050173J
Controlled recovery of the transcription of nanoparticle-bound DNA by intracellular concentrations of glutathione.
G. Han (2005)
10.1021/BC050335B
Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
Vivechana Dixit (2006)
10.1023/A:1011975120776
Solid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
A. Bargoni (2004)
10.1016/S0168-3659(02)00028-7
Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide.
W. Leobandung (2002)
10.1016/j.addr.2007.08.044
Protein nanoparticles as drug carriers in clinical medicine.
M. Hawkins (2008)
10.1016/S0168-3659(03)00200-1
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
A. Chauhan (2003)
10.1021/JP035972I
Characterization of Gold Nanoparticles Synthesized Using Sucrose by Seeding Formation in the Solid Phase and Seeding Growth in Aqueous Solution
Z. Qi (2004)
10.1002/ANIE.200300624
Theoretical chemistry of gold.
P. Pyykkö (2004)
10.1002/jps.21347
Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.
C. Reis (2008)
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
Anne Saupe (2005)
10.1002/APP.23309
Synthesis of amphiphilic hyperbranched polyglycerol polymers and their application as template for size control of gold nanoparticles
D. Wan (2006)
10.1016/J.IJPHARM.2003.10.006
Deformable liposomes for dermal administration of methotrexate.
M. Trotta (2004)
10.1136/ard.2006.065128
Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial
Matthias Rother (2007)
10.1038/nbt875
The potential environmental impact of engineered nanomaterials
V. Colvin (2003)
10.1016/S0378-5173(96)04697-2
Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique
D. Quintanar-Guerrero (1996)
10.1002/JBM.A.30882
Amine-containing core-shell nanoparticles as potential drug carriers for intracellular delivery.
Min Feng (2007)
10.1007/s00285-008-0214-y
Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation
J. Sinek (2009)



This paper is referenced by
10.1007/978-3-030-29207-2_2
Nanocarriers as Potential Targeted Drug Delivery for Cancer Therapy
Gautam Singhvi (2020)
10.1016/J.MICROMESO.2013.11.036
In situ synthesis of a drug-loaded MOF at room temperature
Negar Motakef-Kazemi (2014)
10.2174/1877912304666140304000133
Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
P. Martins (2014)
10.1371/journal.pone.0038553
Vault Nanocapsules as Adjuvants Favor Cell-Mediated over Antibody-Mediated Immune Responses following Immunization of Mice
U. Kar (2012)
10.1016/j.ejpb.2020.01.005
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Maria Inês Teixeira (2020)
10.1007/s11051-020-04848-0
Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations
B. Subramaniam (2020)
10.1111/ijd.13902
Recent advances and development in epidermal and dermal drug deposition enhancement technology
Babar Iqbal (2018)
10.1080/08982104.2019.1585448
Ascorbic acid derivative-loaded modified aspasomes: formulation, in vitro, ex vivo and clinical evaluation for melasma treatment
M. H. Aboul-Einien (2019)
10.1039/c5cp02717a
Structural characterization of functionalized gold nanoparticles for drug delivery in cancer therapy: a NMR based approach.
S. Coelho (2015)
10.1016/j.ejps.2020.105412
Drug Delivery Systems Based on Nanoparticles and Related Nanostuctures.
A. Nikezić (2020)
10.1016/J.POLYMER.2015.10.008
Water soluble, biodegradable amphiphilic polymeric nanoparticles and the molecular environment of hydrophobic encapsulates: Consistency between simulation and experiment
R. Miller (2015)
10.1007/978-1-4614-9387-7_7
Applications of Food-Grade Nanoemulsions
C. Anandharamakrishnan (2014)
10.4028/www.scientific.net/AMR.829.247
Metal Organic Framework [Zn2(1,4-bdc)2(dabco)]n as Drug Delivery System
Negar Motakef-Kazemi (2013)
10.2174/0929867326666190624155938
Formulating SLN and NLC as innovative drug delivery systems for non-invasive routes of drug administration.
Bruno Fonseca-Santos (2019)
Incorporation of elastase inhibitor in silk fibroin nanoparticles for transdermal delivery
A. V. Ferreira (2013)
10.1111/cbdd.12750
Enhanced Cytotoxicity to Cancer Cells by Codelivery and Controlled Release of Paclitaxel‐loaded Sirolimus‐conjugated Albumin Nanoparticles
Hossein Behrouz (2016)
10.1016/B978-0-323-46152-8.00017-2
Nanocarriers for plant-derived natural compounds
O. Bayraktar (2017)
10.1016/j.nano.2015.06.008
Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems.
M. Gaspar (2015)
10.1007/978-3-319-63633-7_3
Nanotechnology for Therapeutics
Anujit Ghosal (2017)
10.17219/pim/99993
Starch nanoparticles in drug delivery: A review.
Michael A. Odeniyi (2018)
10.5772/51729
Niosomes as Carrier in Dermal Drug Delivery
Yahya Rahimpour (2012)
10.1007/978-3-030-10614-0_39-1
Polymeric and Ceramic Nanoparticles: Possible Role in Biomedical Applications
S. Kaushik (2020)
10.1016/J.EURPOLYMJ.2018.09.011
Formulation of functionalized PLGA nanoparticles with folic acid-conjugated chitosan for carboplatin encapsulation
Daniel de Moraes Profirio (2018)
10.1016/S1773-2247(13)50016-5
Nano and microtechnologies for ophthalmic administration, an overview
R. Herrero-Vanrell (2013)
10.1016/j.tifs.2020.05.004
Phytosterols as the core or stabilizing agent in different nanocarriers
Maryam Mohammadi (2020)
A New Interfacial Cross Linking Technique: Preparation, Characterization and Evaluation of Calcium alginate Nanoparticles as a Protein Delivery System
P. Singh (2013)
10.1007/978-3-319-50909-9_11-1
Introduction to Pharmaceuticals
Keshav S. Moharir (2020)
10.1016/J.CHEMPHYS.2019.110462
Synthesis, characterization and spectroscopic studies of surfactant loaded antiulcer drug into Chitosan nanoparticles for interaction with bovine serum albumin
Mohsen T.A. Qashqoosh (2019)
10.3390/ma11030394
Protein-Based Nanoparticle Preparation via Nanoprecipitation Method
Mohamad Tarhini (2018)
10.1007/s00253-018-9352-3
Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond
J. Iqbal (2018)
10.1007/978-1-4939-6355-3_16
Nanoformulations of Antiepileptic Drugs: In Vitro and In Vivo Studies
M. E. Ruiz (2016)
10.4155/ppa.13.79
Pharmaceutical and biomedical applications of lipid-based nanocarriers.
C. Carbone (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar